5-tert-butyl-2-(3-dimethylaminomethylphenyl)-2H-pyrazol-3-ylamine | 898538-00-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-tert-butyl-2-(3-dimethylaminomethylphenyl)-2H-pyrazol-3-ylamine
• 英文别名: 5-Tert-butyl-2-[3-[(dimethylamino)methyl]phenyl]pyrazol-3-amine
• CAS: 898538-00-6
• 化学式: C₁₆H₂₄N₄
• 分子量: 272.393
• InChiKey: WCSPTKLLCVYMJI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  47.1
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Triazolopyridine Compounds
  申请人：Lewthwaite Russell Andrew

  公开号：US20090012079A1

  公开（公告）日：2009-01-08

  A compound of formula (Ia): or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof, or a compound of formula (Ib): or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof, and the use of a compound of formula (Ia) or (Ib) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airway diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.

  化合物式(Ia)的化合物：或其药学上可接受的盐和/或溶剂（包括水合物），或化合物式(Ib)的化合物：或其药学上可接受的盐和/或溶剂（包括水合物），以及化合物式(Ia)或(Ib)在治疗TNF介导的疾病、障碍或病况，或p38介导的疾病、障碍或病况中的应用，特别是过敏性和非过敏性呼吸道疾病，更具体地说是阻塞性或炎症性呼吸道疾病，优选慢性阻塞性肺疾病。
• COMBINATIONS COMPRISING A VEGF RECEPTOR INHIBITOR AND A PENETRATION ENHANCER
  申请人：Novartis AG

  公开号：EP1945217A2

  公开（公告）日：2008-07-23
• TRIAZOLOPYRIDINE COMPOUNDS
  申请人：Pfizer Limited

  公开号：EP1984363A1

  公开（公告）日：2008-10-29
• Bicyclic Amides as Kinase Inhibitors
  申请人：Bold Guido

  公开号：US20080287427A1

  公开（公告）日：2008-11-20

  The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising en a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.
• Combinations Comprising a Vegf Receptor Inhibitor
  申请人：Billich Andreas

  公开号：US20080306058A1

  公开（公告）日：2008-12-11

  A composition comprising a VEGF receptor inhibitor and a penetration enhancer and uses thereof.